ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autologous Biologics Market Insights, Forecast to 2029
Published Date: September 2023
|
Report Code: QYRE-Auto-1Q11891
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autologous Biologics Market Research Report 2022
BUY CHAPTERS

Global Autologous Biologics Market Insights, Forecast to 2029

Code: QYRE-Auto-1Q11891
Report
September 2023
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Vericel Corporation
BioTime
PHARMICELL
Brainstorm Cell Therapeutics
Opexa Therapeutics Inc.
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Pharmicell Co., Inc

Autologous Biologics Market

The global Autologous Biologics market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Autologous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Autologous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Autologous Biologics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Autologous Biologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Autologous Biologics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Autologous Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Autologous Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Autologous Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Autologous Biologics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx, etc.

Scope of Autologous Biologics Market Report

Report Metric Details
Report Name Autologous Biologics Market
Segment by Type
  • Adipose Tissue
  • Plasma
  • Others
Segment by Application
  • Hospitals
  • Ambulatory Centers
  • Research Centers
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Autologous Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Autologous Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
  • Chapter 8: China by type, by application sales and revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Autologous Biologics sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Autologous Biologics Market report?

Ans: The main players in the Autologous Biologics Market are Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics

What are the Application segmentation covered in the Autologous Biologics Market report?

Ans: The Applications covered in the Autologous Biologics Market report are Hospitals, Ambulatory Centers, Research Centers

What are the Type segmentation covered in the Autologous Biologics Market report?

Ans: The Types covered in the Autologous Biologics Market report are Adipose Tissue, Plasma, Others

1 Study Coverage
1.1 Autologous Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Autologous Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Adipose Tissue
1.2.3 Plasma
1.2.4 Others
1.3 Market by Application
1.3.1 Global Autologous Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Centers
1.3.4 Research Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Autologous Biologics Sales Estimates and Forecasts 2018-2029
2.2 Global Autologous Biologics Revenue by Region
2.2.1 Global Autologous Biologics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Autologous Biologics Revenue by Region (2018-2023)
2.2.3 Global Autologous Biologics Revenue by Region (2024-2029)
2.2.4 Global Autologous Biologics Revenue Market Share by Region (2018-2029)
2.3 Global Autologous Biologics Sales Estimates and Forecasts 2018-2029
2.4 Global Autologous Biologics Sales by Region
2.4.1 Global Autologous Biologics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Autologous Biologics Sales by Region (2018-2023)
2.4.3 Global Autologous Biologics Sales by Region (2024-2029)
2.4.4 Global Autologous Biologics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Autologous Biologics Sales by Manufacturers
3.1.1 Global Autologous Biologics Sales by Manufacturers (2018-2023)
3.1.2 Global Autologous Biologics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Autologous Biologics in 2022
3.2 Global Autologous Biologics Revenue by Manufacturers
3.2.1 Global Autologous Biologics Revenue by Manufacturers (2018-2023)
3.2.2 Global Autologous Biologics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Autologous Biologics Revenue in 2022
3.3 Global Key Players of Autologous Biologics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Autologous Biologics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Autologous Biologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Autologous Biologics, Product Offered and Application
3.8 Global Key Manufacturers of Autologous Biologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Autologous Biologics Sales by Type
4.1.1 Global Autologous Biologics Historical Sales by Type (2018-2023)
4.1.2 Global Autologous Biologics Forecasted Sales by Type (2024-2029)
4.1.3 Global Autologous Biologics Sales Market Share by Type (2018-2029)
4.2 Global Autologous Biologics Revenue by Type
4.2.1 Global Autologous Biologics Historical Revenue by Type (2018-2023)
4.2.2 Global Autologous Biologics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Autologous Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Autologous Biologics Price by Type
4.3.1 Global Autologous Biologics Price by Type (2018-2023)
4.3.2 Global Autologous Biologics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Autologous Biologics Sales by Application
5.1.1 Global Autologous Biologics Historical Sales by Application (2018-2023)
5.1.2 Global Autologous Biologics Forecasted Sales by Application (2024-2029)
5.1.3 Global Autologous Biologics Sales Market Share by Application (2018-2029)
5.2 Global Autologous Biologics Revenue by Application
5.2.1 Global Autologous Biologics Historical Revenue by Application (2018-2023)
5.2.2 Global Autologous Biologics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Autologous Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Autologous Biologics Price by Application
5.3.1 Global Autologous Biologics Price by Application (2018-2023)
5.3.2 Global Autologous Biologics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Autologous Biologics Market Size by Type
6.1.1 US & Canada Autologous Biologics Sales by Type (2018-2029)
6.1.2 US & Canada Autologous Biologics Revenue by Type (2018-2029)
6.2 US & Canada Autologous Biologics Market Size by Application
6.2.1 US & Canada Autologous Biologics Sales by Application (2018-2029)
6.2.2 US & Canada Autologous Biologics Revenue by Application (2018-2029)
6.3 US & Canada Autologous Biologics Market Size by Country
6.3.1 US & Canada Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Autologous Biologics Sales by Country (2018-2029)
6.3.3 US & Canada Autologous Biologics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Autologous Biologics Market Size by Type
7.1.1 Europe Autologous Biologics Sales by Type (2018-2029)
7.1.2 Europe Autologous Biologics Revenue by Type (2018-2029)
7.2 Europe Autologous Biologics Market Size by Application
7.2.1 Europe Autologous Biologics Sales by Application (2018-2029)
7.2.2 Europe Autologous Biologics Revenue by Application (2018-2029)
7.3 Europe Autologous Biologics Market Size by Country
7.3.1 Europe Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Autologous Biologics Sales by Country (2018-2029)
7.3.3 Europe Autologous Biologics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Autologous Biologics Market Size
8.1.1 China Autologous Biologics Sales (2018-2029)
8.1.2 China Autologous Biologics Revenue (2018-2029)
8.2 China Autologous Biologics Market Size by Application
8.2.1 China Autologous Biologics Sales by Application (2018-2029)
8.2.2 China Autologous Biologics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Autologous Biologics Market Size by Type
9.1.1 Asia Autologous Biologics Sales by Type (2018-2029)
9.1.2 Asia Autologous Biologics Revenue by Type (2018-2029)
9.2 Asia Autologous Biologics Market Size by Application
9.2.1 Asia Autologous Biologics Sales by Application (2018-2029)
9.2.2 Asia Autologous Biologics Revenue by Application (2018-2029)
9.3 Asia Autologous Biologics Sales by Region
9.3.1 Asia Autologous Biologics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Autologous Biologics Revenue by Region (2018-2029)
9.3.3 Asia Autologous Biologics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Autologous Biologics Market Size by Type
10.1.1 Middle East, Africa and Latin America Autologous Biologics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Autologous Biologics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Autologous Biologics Market Size by Application
10.2.1 Middle East, Africa and Latin America Autologous Biologics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Autologous Biologics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Autologous Biologics Sales by Country
10.3.1 Middle East, Africa and Latin America Autologous Biologics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Autologous Biologics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Autologous Biologics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Vericel Corporation
11.1.1 Vericel Corporation Company Information
11.1.2 Vericel Corporation Overview
11.1.3 Vericel Corporation Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Vericel Corporation Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Vericel Corporation Recent Developments
11.2 BioTime, Inc.
11.2.1 BioTime, Inc. Company Information
11.2.2 BioTime, Inc. Overview
11.2.3 BioTime, Inc. Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 BioTime, Inc. Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BioTime, Inc. Recent Developments
11.3 Pharmicell Co.
11.3.1 Pharmicell Co. Company Information
11.3.2 Pharmicell Co. Overview
11.3.3 Pharmicell Co. Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Pharmicell Co. Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pharmicell Co. Recent Developments
11.4 BrainStorm Cell Therapeutics
11.4.1 BrainStorm Cell Therapeutics Company Information
11.4.2 BrainStorm Cell Therapeutics Overview
11.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BrainStorm Cell Therapeutics Recent Developments
11.5 Opexa Therapeutics, Inc
11.5.1 Opexa Therapeutics, Inc Company Information
11.5.2 Opexa Therapeutics, Inc Overview
11.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Opexa Therapeutics, Inc Recent Developments
11.6 Pharmicell Co., Inc
11.6.1 Pharmicell Co., Inc Company Information
11.6.2 Pharmicell Co., Inc Overview
11.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Pharmicell Co., Inc Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pharmicell Co., Inc Recent Developments
11.7 Neostem
11.7.1 Neostem Company Information
11.7.2 Neostem Overview
11.7.3 Neostem Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Neostem Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Neostem Recent Developments
11.8 Dendreon Corporation
11.8.1 Dendreon Corporation Company Information
11.8.2 Dendreon Corporation Overview
11.8.3 Dendreon Corporation Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Dendreon Corporation Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dendreon Corporation Recent Developments
11.9 Regenexx
11.9.1 Regenexx Company Information
11.9.2 Regenexx Overview
11.9.3 Regenexx Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Regenexx Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Regenexx Recent Developments
11.10 Cytori Therapeutics
11.10.1 Cytori Therapeutics Company Information
11.10.2 Cytori Therapeutics Overview
11.10.3 Cytori Therapeutics Autologous Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Cytori Therapeutics Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cytori Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Autologous Biologics Industry Chain Analysis
12.2 Autologous Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Autologous Biologics Production Mode & Process
12.4 Autologous Biologics Sales and Marketing
12.4.1 Autologous Biologics Sales Channels
12.4.2 Autologous Biologics Distributors
12.5 Autologous Biologics Customers
13 Market Dynamics
13.1 Autologous Biologics Industry Trends
13.2 Autologous Biologics Market Drivers
13.3 Autologous Biologics Market Challenges
13.4 Autologous Biologics Market Restraints
14 Key Findings in The Global Autologous Biologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Vericel Corporation
BioTime
PHARMICELL
Brainstorm Cell Therapeutics
Opexa Therapeutics Inc.
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Pharmicell Co., Inc
List of Tables
    Table 1. Global Autologous Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Table 2. Major Manufacturers of Adipose Tissue
    Table 3. Major Manufacturers of Plasma
    Table 4. Major Manufacturers of Others
    Table 5. Global Autologous Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Table 6. Global Autologous Biologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Autologous Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 8. Global Autologous Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 9. Global Autologous Biologics Revenue Market Share by Region (2018-2023)
    Table 10. Global Autologous Biologics Revenue Market Share by Region (2024-2029)
    Table 11. Global Autologous Biologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 12. Global Autologous Biologics Sales by Region (2018-2023) & (Kg)
    Table 13. Global Autologous Biologics Sales by Region (2024-2029) & (Kg)
    Table 14. Global Autologous Biologics Sales Market Share by Region (2018-2023)
    Table 15. Global Autologous Biologics Sales Market Share by Region (2024-2029)
    Table 16. Global Autologous Biologics Sales by Manufacturers (2018-2023) & (Kg)
    Table 17. Global Autologous Biologics Sales Share by Manufacturers (2018-2023)
    Table 18. Global Autologous Biologics Revenue by Manufacturers (2018-2023) & (US$ Million)
    Table 19. Global Autologous Biologics Revenue Share by Manufacturers (2018-2023)
    Table 20. Global Key Players of Autologous Biologics, Industry Ranking, 2021 VS 2022 VS 2023
    Table 21. Autologous Biologics Price by Manufacturers 2018-2023 (US$/Kg)
    Table 22. Global Autologous Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Autologous Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Biologics as of 2022)
    Table 24. Global Key Manufacturers of Autologous Biologics, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Autologous Biologics, Product Offered and Application
    Table 26. Global Key Manufacturers of Autologous Biologics, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 29. Global Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 30. Global Autologous Biologics Sales Share by Type (2018-2023)
    Table 31. Global Autologous Biologics Sales Share by Type (2024-2029)
    Table 32. Global Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 33. Global Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 34. Global Autologous Biologics Revenue Share by Type (2018-2023)
    Table 35. Global Autologous Biologics Revenue Share by Type (2024-2029)
    Table 36. Autologous Biologics Price by Type (2018-2023) & (US$/Kg)
    Table 37. Global Autologous Biologics Price Forecast by Type (2024-2029) & (US$/Kg)
    Table 38. Global Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 39. Global Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 40. Global Autologous Biologics Sales Share by Application (2018-2023)
    Table 41. Global Autologous Biologics Sales Share by Application (2024-2029)
    Table 42. Global Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 43. Global Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 44. Global Autologous Biologics Revenue Share by Application (2018-2023)
    Table 45. Global Autologous Biologics Revenue Share by Application (2024-2029)
    Table 46. Autologous Biologics Price by Application (2018-2023) & (US$/Kg)
    Table 47. Global Autologous Biologics Price Forecast by Application (2024-2029) & (US$/Kg)
    Table 48. US & Canada Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 49. US & Canada Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 50. US & Canada Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 51. US & Canada Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 52. US & Canada Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 53. US & Canada Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 54. US & Canada Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 55. US & Canada Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 56. US & Canada Autologous Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 57. US & Canada Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 58. US & Canada Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 59. US & Canada Autologous Biologics Sales by Country (2018-2023) & (Kg)
    Table 60. US & Canada Autologous Biologics Sales by Country (2024-2029) & (Kg)
    Table 61. Europe Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 62. Europe Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 63. Europe Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 64. Europe Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 65. Europe Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 66. Europe Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 67. Europe Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 68. Europe Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 69. Europe Autologous Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 70. Europe Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 71. Europe Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 72. Europe Autologous Biologics Sales by Country (2018-2023) & (Kg)
    Table 73. Europe Autologous Biologics Sales by Country (2024-2029) & (Kg)
    Table 74. China Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 75. China Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 76. China Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 77. China Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 78. China Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 79. China Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 80. China Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 81. China Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 82. Asia Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 83. Asia Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 84. Asia Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 85. Asia Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 86. Asia Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 87. Asia Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 88. Asia Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 89. Asia Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 90. Asia Autologous Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 91. Asia Autologous Biologics Revenue by Region (2018-2023) & (US$ Million)
    Table 92. Asia Autologous Biologics Revenue by Region (2024-2029) & (US$ Million)
    Table 93. Asia Autologous Biologics Sales by Region (2018-2023) & (Kg)
    Table 94. Asia Autologous Biologics Sales by Region (2024-2029) & (Kg)
    Table 95. Middle East, Africa and Latin America Autologous Biologics Sales by Type (2018-2023) & (Kg)
    Table 96. Middle East, Africa and Latin America Autologous Biologics Sales by Type (2024-2029) & (Kg)
    Table 97. Middle East, Africa and Latin America Autologous Biologics Revenue by Type (2018-2023) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Autologous Biologics Revenue by Type (2024-2029) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Autologous Biologics Sales by Application (2018-2023) & (Kg)
    Table 100. Middle East, Africa and Latin America Autologous Biologics Sales by Application (2024-2029) & (Kg)
    Table 101. Middle East, Africa and Latin America Autologous Biologics Revenue by Application (2018-2023) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Autologous Biologics Revenue by Application (2024-2029) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Autologous Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 104. Middle East, Africa and Latin America Autologous Biologics Revenue by Country (2018-2023) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Autologous Biologics Revenue by Country (2024-2029) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Autologous Biologics Sales by Country (2018-2023) & (Kg)
    Table 107. Middle East, Africa and Latin America Autologous Biologics Sales by Country (2024-2029) & (Kg)
    Table 108. Vericel Corporation Company Information
    Table 109. Vericel Corporation Description and Major Businesses
    Table 110. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 111. Vericel Corporation Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Vericel Corporation Recent Developments
    Table 113. BioTime, Inc. Company Information
    Table 114. BioTime, Inc. Description and Major Businesses
    Table 115. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 116. BioTime, Inc. Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. BioTime, Inc. Recent Developments
    Table 118. Pharmicell Co. Company Information
    Table 119. Pharmicell Co. Description and Major Businesses
    Table 120. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 121. Pharmicell Co. Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Pharmicell Co. Recent Developments
    Table 123. BrainStorm Cell Therapeutics Company Information
    Table 124. BrainStorm Cell Therapeutics Description and Major Businesses
    Table 125. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 126. BrainStorm Cell Therapeutics Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. BrainStorm Cell Therapeutics Recent Developments
    Table 128. Opexa Therapeutics, Inc Company Information
    Table 129. Opexa Therapeutics, Inc Description and Major Businesses
    Table 130. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 131. Opexa Therapeutics, Inc Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Opexa Therapeutics, Inc Recent Developments
    Table 133. Pharmicell Co., Inc Company Information
    Table 134. Pharmicell Co., Inc Description and Major Businesses
    Table 135. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 136. Pharmicell Co., Inc Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Pharmicell Co., Inc Recent Developments
    Table 138. Neostem Company Information
    Table 139. Neostem Description and Major Businesses
    Table 140. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 141. Neostem Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Neostem Recent Developments
    Table 143. Dendreon Corporation Company Information
    Table 144. Dendreon Corporation Description and Major Businesses
    Table 145. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 146. Dendreon Corporation Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Dendreon Corporation Recent Developments
    Table 148. Regenexx Company Information
    Table 149. Regenexx Description and Major Businesses
    Table 150. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 151. Regenexx Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Regenexx Recent Developments
    Table 153. Cytori Therapeutics Company Information
    Table 154. Cytori Therapeutics Description and Major Businesses
    Table 155. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
    Table 156. Cytori Therapeutics Autologous Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Cytori Therapeutics Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Autologous Biologics Distributors List
    Table 161. Autologous Biologics Customers List
    Table 162. Autologous Biologics Market Trends
    Table 163. Autologous Biologics Market Drivers
    Table 164. Autologous Biologics Market Challenges
    Table 165. Autologous Biologics Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Autologous Biologics Product Picture
    Figure 2. Global Autologous Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Autologous Biologics Market Share by Type in 2022 & 2029
    Figure 4. Adipose Tissue Product Picture
    Figure 5. Plasma Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Autologous Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Autologous Biologics Market Share by Application in 2022 & 2029
    Figure 9. Hospitals
    Figure 10. Ambulatory Centers
    Figure 11. Research Centers
    Figure 12. Autologous Biologics Report Years Considered
    Figure 13. Global Autologous Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Autologous Biologics Revenue 2018-2029 (US$ Million)
    Figure 15. Global Autologous Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
    Figure 16. Global Autologous Biologics Revenue Market Share by Region (2018-2029)
    Figure 17. Global Autologous Biologics Sales 2018-2029 ((Kg)
    Figure 18. Global Autologous Biologics Sales Market Share by Region (2018-2029)
    Figure 19. US & Canada Autologous Biologics Sales YoY (2018-2029) & (Kg)
    Figure 20. US & Canada Autologous Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 21. Europe Autologous Biologics Sales YoY (2018-2029) & (Kg)
    Figure 22. Europe Autologous Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 23. China Autologous Biologics Sales YoY (2018-2029) & (Kg)
    Figure 24. China Autologous Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 25. Asia (excluding China) Autologous Biologics Sales YoY (2018-2029) & (Kg)
    Figure 26. Asia (excluding China) Autologous Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Autologous Biologics Sales YoY (2018-2029) & (Kg)
    Figure 28. Middle East, Africa and Latin America Autologous Biologics Revenue YoY (2018-2029) & (US$ Million)
    Figure 29. The Autologous Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
    Figure 30. The Top 5 and 10 Largest Manufacturers of Autologous Biologics in the World: Market Share by Autologous Biologics Revenue in 2022
    Figure 31. Global Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 32. Global Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 33. Global Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 34. Global Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 35. Global Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 36. US & Canada Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 37. US & Canada Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 38. US & Canada Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 39. US & Canada Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 40. US & Canada Autologous Biologics Revenue Share by Country (2018-2029)
    Figure 41. US & Canada Autologous Biologics Sales Share by Country (2018-2029)
    Figure 42. U.S. Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 43. Canada Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 44. Europe Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 45. Europe Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 46. Europe Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 47. Europe Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 48. Europe Autologous Biologics Revenue Share by Country (2018-2029)
    Figure 49. Europe Autologous Biologics Sales Share by Country (2018-2029)
    Figure 50. Germany Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 51. France Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 52. U.K. Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 53. Italy Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 54. Russia Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 55. China Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 56. China Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 57. China Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 58. China Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 59. Asia Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 60. Asia Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 61. Asia Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 62. Asia Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 63. Asia Autologous Biologics Revenue Share by Region (2018-2029)
    Figure 64. Asia Autologous Biologics Sales Share by Region (2018-2029)
    Figure 65. Japan Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 66. South Korea Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 67. China Taiwan Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 68. Southeast Asia Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 69. India Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Autologous Biologics Sales Market Share by Type (2018-2029)
    Figure 71. Middle East, Africa and Latin America Autologous Biologics Revenue Market Share by Type (2018-2029)
    Figure 72. Middle East, Africa and Latin America Autologous Biologics Sales Market Share by Application (2018-2029)
    Figure 73. Middle East, Africa and Latin America Autologous Biologics Revenue Market Share by Application (2018-2029)
    Figure 74. Middle East, Africa and Latin America Autologous Biologics Revenue Share by Country (2018-2029)
    Figure 75. Middle East, Africa and Latin America Autologous Biologics Sales Share by Country (2018-2029)
    Figure 76. Brazil Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 77. Mexico Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 78. Turkey Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 79. Israel Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 80. GCC Countries Autologous Biologics Revenue (2018-2029) & (US$ Million)
    Figure 81. Autologous Biologics Value Chain
    Figure 82. Autologous Biologics Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions